Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-08

FDA Approved: DIGOXIN — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved Aurobindo Pharma Limited's original application for a generic digoxin product, enabling marketing in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIGOXIN (Digoxin)

Snippet

ORIG AP for DIGOXIN (DIGOXIN)